This federal contract award, valued at $1,565.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of a pharmaceutical product, ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of November 1, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
This specific contract award was not designated with a set-aside, indicating open competition. The contract type is Delivery Order with a Firm Fixed Price pricing structure.
Generated 1/30/25, 9:03 AM